b'Veteran OwndedleSb maasi lD le u Bc i v r e S n i ss s eC V ETRANSFER EFFICACY STUDY AIONX makes no claims herein.See bottom for full legal disclaimer.REDUCTION OF BACTERIA ON EVEN NON-COVERED SURFACESAfter the introduction of cleanSURFACES, the abundance of a large number of bacterial species was found to be eliminated or significantly reduced throughout the unit.Not only did cleanSURFACES keep covered surfaces continuously clean, but many key surfaces that were not coveredby the product were also found to be significantly cleaner. The below chart sets forth summaries of the bacterial species with a change in mean abundance (p-value 0.1) on each of the non-covered surfaces sampled.Total # of species withSpecies significantly Total specieschange in meanSpecies eliminatedreduced but not eliminated eliminated or reduced abundance Keyboard, patient room182162(89%)14(8%)176(97%) Mouse, patient room270236(87%)27(10%)263(97%) IV pump, patient room196176(90%)14(7%)190(97%) Supply scanner, patient room253214(85%)28(11%)242(96%) Nurse ID badge114101(89%)8(7%)109(96%) Keyboard, nurse station172130(76%)34(20%)164(95%) Phone, nurse station14484(58%)35(24%)119(83%) Mouse, nurse station4918(37%)4(8%)22(45%) Cellphone330(0%)13(39%)13(39%) Glucometer, nurse station3913(33%)2(5%)15(38%) Stethoscope490(0%)15(31%)15(31%) Chair rails, nurse station9117(19%)1(1%)18(20%)IMPACT ON CLINICALLY RELEVANT BACTERIAL SPECIES HOW THE ANALYSIS WAS DONEResearchers from Contamination Source Identification, LLC Many clinically relevant bacterial species were among those eliminated or significantly reduced during the post- (Huntingdon, PA), designed the study, analyzed the samples, and intervention period.The below chart shows percentperformed the statistical calculations. Metagenomic analysis of the samples was done using 16S rRNA amplicon sequencing reduction in abundance across all samples of several keytechniques coupled with a proprietary bioinformatic data bacterial species. (p 0.05) pipeline. Results of this analysis revealed the presence of particular bacterial taxa in the samples as well as each taxons % Reductionabundance.Bacterial Species(All Samples)C. diff100 Enterococcus spp.79 Bacteroides fragilis100cleanSURFACES were created by Staphyloccocus aureus45 Acinetobacter baumannii100Aionx Antimicrobial Technologies, Inc. 515 Rear West Chocolate Avenue Pathogenic Streptococcus spp.45Hershey, PA 15044 Morganella morganii100(888) 512-4669 | email@example.com aionx.com Mycobacterium abscessus100 24 AionX cleanSURFACESuse a technology registered with the EPA (Reg. No. 91681-1) as an antimicrobial agent that effectively inhibits the growth of bacteria, fungi, algae, mold, and mildew that cause unpleasant odors, discoloration, staining, deterioration or corrosion on surfaces to which it is applied. The EPA has not reviewed or approved,nor does AIONX make, any claims that its technology has efficacy against any particular pathogenic microbes. The use of cleanSURFACES is a supplement to and not a substitute for standard infection control practices.'